Sleep medication study for smokers wanting to cut back
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This study tests a sleep medication called daridorexant to see if it helps smokers sleep better and feel more alert during the day, which might make it easier to cut back on smoking. You'll take the medication for 3 weeks and track your sleep and smoking at home.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a cigarette smoker between 18 and 55 years old
- Smoke more than 10 cigarettes a day and have smoked for at least a year
- Be willing to try to cut back or stop smoking for 3 weeks during the study
- Be able to use an iPhone (iOS 17 or newer) and take a 5-minute mobile test several times a day
- Be willing to wear a sleep monitor at night and keep a simple diary
- Be able to attend 3 in-person study visits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a sleep medication called daridorexant to see if it helps people with both insomnia and alcohol use disorder sleep better and reduce drinking. It may offer a new way to address both problems together.
This study tests whether improving sleep can help people quit smoking and avoid relapse. It uses brain scans, a quitting medication, and counseling.
This study follows adults with insomnia who are prescribed a new sleep medication called daridorexant. It aims to see how well the medication works in a real-world setting, and to monitor its safety and effects on sleep.
This study tests an experimental sleep aid called daridorexant for people who have both depression and insomnia. It aims to see if the drug can improve sleep without worsening depression symptoms.
This trial tests whether daridorexant can improve sleep in people who have mild cognitive impairment or early Alzheimer’s disease and struggle with insomnia. It may help by improving how long and how well you sleep, with monitoring of sleep patterns and memory-related measures.
This study tests a wellness-based smoking-cessation program (including the stop-smoking medicine varenicline) for people living with HIV who want to quit. It aims to help you reduce or stop smoking while monitoring safety, sleep, and mental health during the program.
Hear when a new Nicotine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.